Gilead Sciences Inc.has begun sharing glimpses of the massive scaleup underway in the manufacture of its remdesivir, authorized in the US for emergency use and approved in Japan for treatment of the SARS-CoV-2 injection that causes COVID-19.
There are a growing number of clinical trials to supply as well as expanded access, compassionate use and emergency authorization...





